Definition of gross tumor volume in lung cancer: Inter-observer variability

Radiotherapy and Oncology

Volumn 62, Issue 1, 2002, Pages 37-49

  Van de Steene, Jan ^a   Linthout, Nadine ^a   De Mey, Johan ^a   Vinh Hung, Vincent ^a   Claassens, Cornelia ^a   Noppen, Marc ^a   Bel, Arjan ^a   Storme, Guy ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Conformal radiotherapy; GTV definition; Inter observer variability; Lung cancer; Quality control

Indexed keywords

CANCER CONTROL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DOSIMETRY; HUMAN; HUMAN EXPERIMENT; LUNG CANCER; LYMPH NODE METASTASIS; METHODOLOGY; PRIORITY JOURNAL; RADIATION DOSE; TUMOR VOLUME;

EID: 0036164338     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00453-4     Document Type: Conference Paper

References (50)

1. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
2. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer
3. Manual for staging of cancer
4. Impact of on-line setup corrections on the delivered dose and the target margins for routine irradiation of lung cancer
5. Fitting of normal tissue tolerance data to an analytic function
6. CT and PET lung image registration and fusion in radiotherapy treatment planning using the chamfer-matching method
7. Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles
8. Target position variability throughout prostate radiotherapy
9. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?
10. Tolerance of normal tissue to therapeutic irradiation
11. Management of hilar and mediastinal lymph nodes with radiation therapy in the treatment of lung cancer
12. Intra- and inter-observer variability in contouring prostate and seminal vesicles: Implications for conformal treatment planning
13. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung
14. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer
15. Treatment and planning decisions in non-small cell carcinoma of the lung: An Australasian patterns of practice study
16. Laryngeal tumor volume measurements determined with CT: A study on intra- and interobserver variability
17. Radiation therapy alone for stage I non-small cell lung cancer
18. Automated planning target volume generation: An evaluation pitting a computer-based tool against human experts
19. Consistency of three-dimensional planning target volumes across physicians and institutions
20. Quality assessment of medical decision making in radiation oncology: Variability in target volume delineation for brain tumours
21. Clinical variability of target volume description in conformal radiotherapy planning
22. Optimization of radiation therapy. III. A method of assessing complication probabilities from dose-volume histograms
23. Regional lymph node classification for lung cancer staging
24. Revision in the international system for lung cancer staging
25. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture
26. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor
27. Preoperative staging of non-small-cell lung cancer with positron-emission tomography
28. Dose escalation for non-small cell lung cancer using conformal radiation therapy
29. Image registration: An essential part of radiation therapy treatment planning
30. Influence of the positioning error on 3D conformal dose distributions during fractionated radiotherapy
31. Improving treatment planning accuracy through multimodality imaging
32. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer
33. The portable virtual simulator
34. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability
35. Variability of target volume delineation in cervical esophageal cancer
36. Conformal therapy
37. Conformal therapy
38. Quantitative computer-assisted analysis vs. visual estimation of MR imaging response of brain metastases to radiotherapy
39. The role of uncertainty analysis in treatment planning
40. Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer
41. Comparison of treatment techniques for lung cancer
42. The clinician is a critical prognostic factor in IMRT practice
43. Electronic portal imaging with on-line correction of setup error in thoracic irradiation: Clinical evaluation
44. Quality assurance in cancer treatment. Report of a working party from the European School of Oncology
45. Mediastinal lymph node (MLN) staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer (NSCLC): A prospective analysis of 50 cases
46. Implementation of three dimensional conformal radiation therapy: Prospects opportunities, and challenges
47. The use of active breathing control (ABC) to reduce margin for breathing motion
48. Differences in target outline delineation from CT scans of brain tumours using different methods and different observers
49. Differences in gross target volumes on contrast vs. noncontrast CT scans utilized for conformal radiation therapy treatment planning for prostate carcinoma